Desmopressin Acetate Tablets 0 — Class II drug recall D-0072-2023
Terminated recall by Heritage Pharmaceuticals Inc, reported 2022-12-07, distributed nationwide. Subpotent Drug
| Recall number | D-0072-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Heritage Pharmaceuticals Inc, East Brunswick, NJ, United States |
| Recall initiated | 2022-11-23 |
| Classified | 2022-11-29 |
| Reported by FDA | 2022-12-07 |
| Terminated | 2023-12-13 |
| Distributed | Nationwide (US) |
| Reason classes | potency |
| NDC | 23155-0489, 23155-0489-01, 23155-0489-05, 23155-0490, 23155-0490-01, 23155-0490-05 |
| Lot numbers | 220440A |
| Expiration dates | 2024-05 |
Product
Desmopressin Acetate Tablets 0.2mg, 100-count bottles, RX Only, Distributed by: Avet Pharmaceuticals Inc. East Brunswick, NJ 08816, NDC 23155-490-01
Reason for recall
Subpotent Drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0072-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.